These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1963117)

  • 41. [The perspective of global eradication of poliomyelitis].
    Knolle H; Egli A; Candrian U
    Gesundheitswesen; 2004 Jan; 66(1):1-6. PubMed ID: 14767784
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The work of the WHO Consultative Group on Poliomyelitis Vaccines.
    Cockburn WC
    Bull World Health Organ; 1988; 66(2):143-54. PubMed ID: 2840219
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sabin monovalent oral polio vaccines: review of past experiences and their potential use after polio eradication.
    Cáceres VM; Sutter RW
    Clin Infect Dis; 2001 Aug; 33(4):531-41. PubMed ID: 11462191
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Studies on the incidence and genetic characteristics of polioviruses during vaccination with polyvalent vaccines].
    Jarzqbek Z; Najberg G; Sadowski W
    Przegl Epidemiol; 1979; 33(2):277-83. PubMed ID: 225761
    [No Abstract]   [Full Text] [Related]  

  • 45. [Advantages and inconveniences of inactive and live antipoliomyelitis vaccines].
    Melnick JL
    Bull World Health Organ; 1978; 56(5):677-98. PubMed ID: 310715
    [No Abstract]   [Full Text] [Related]  

  • 46. New approaches to poliovirus diagnosis using laboratory techniques: memorandum from a WHO meeting.
    Bull World Health Organ; 1992; 70(1):27-33. PubMed ID: 1348972
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The behaviour of Sabin attenuated poliovirus strains in the central nervous system of rhesus monkeys.
    Arya SC
    J Biol Stand; 1977; 5(4):275-81. PubMed ID: 200628
    [No Abstract]   [Full Text] [Related]  

  • 48. Vaccination against poliomyelitis with live virus vaccines. 6. Changes in Sabin type II oral vaccine virus after human passage.
    DANE DS; DICK GW; BRIGGS M; NELSON R; McALISTER J; CONNOLLY JH; HAIRE M; McKEOWN F; FIELD CM
    Br Med J; 1961 Jul; 2(5247):259-65. PubMed ID: 13719566
    [No Abstract]   [Full Text] [Related]  

  • 49. [Some questions of the theory of live vaccine and vaccination against poliomyelitis with Sabin vaccine].
    GINSBURG NN
    Vopr Virusol; 1959; 4():620-4. PubMed ID: 13850246
    [No Abstract]   [Full Text] [Related]  

  • 50. Vaccination against poliomyelitis with live virus vaccines. 8. Changes in Sabin type I oral vaccine virus after multiplication in the intestinal tract.
    DANE DS; DICK GW; BRIGGS M; NELSON R; McALISTER J; CONNOLLY JH; McKEOWN F; FIELD CM
    Br Med J; 1961 Jul; 2(5247):269-71. PubMed ID: 13719567
    [No Abstract]   [Full Text] [Related]  

  • 51. Production and control of live oral poliovirus vaccine in WI-38 human diploid cells.
    Stones PB
    Dev Biol Stand; 1976 Dec 13-15; 37():251-3. PubMed ID: 1036401
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vaccine-associated paralytic poliomyelitis: a case report.
    Ilic MD; Obradovic SD
    Jpn J Infect Dis; 2014; 67(2):135-6. PubMed ID: 24647260
    [No Abstract]   [Full Text] [Related]  

  • 53. Large-scale use of Sabin type 2 attenuated poliovirus vaccine in Singapore during a type 1 poliomyelitis epidemic.
    HALE JH; DORAISINGHAM M; KANAGARATNAM K; LEONG KW; MONTEIRO ES
    Br Med J; 1959 Jun; 1(5137):1541-9. PubMed ID: 13662613
    [No Abstract]   [Full Text] [Related]  

  • 54. IN VITRO MARKER OF POLIOVIRUSES OBTAINED FROM HUMAN STOOLS AFTER ADMINISTRATION OF ATTENUATED LIVE POLIOVIRUS VACCINE (SABIN).
    KASAHARA S; YOSHIOKA I; YAMAGISHI H; AIZAWA C
    Kitasato Arch Exp Med; 1963 Dec; 36():77-86. PubMed ID: 14318783
    [No Abstract]   [Full Text] [Related]  

  • 55. Use of a mathematical model for neurovirulence assay of attenuated poliovirus.
    Arya SC
    J Biol Stand; 1977; 5(4):283-7. PubMed ID: 200629
    [No Abstract]   [Full Text] [Related]  

  • 56. MASS VACCINATION WITH ORAL LIVE-VIRUS VACCINE FOR PREVENTION OF POLIOMYELITIS IN THE USSR AND OTHER COUNTRIES.
    MATVEYEV MP
    Indian J Pediatr; 1964 Feb; 31():46-50. PubMed ID: 14133641
    [No Abstract]   [Full Text] [Related]  

  • 57. Polio vaccines and polioviruses.
    Br Med J; 1977 Jun; 1(6077):1617-8. PubMed ID: 194649
    [No Abstract]   [Full Text] [Related]  

  • 58. Evolution of poliovirus since introduction of attenuated vaccine.
    Cossart YE
    Br Med J; 1977 Jun; 1(6077):1621-3. PubMed ID: 194650
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The use of poliovirus vaccine live, oral (Sabin), trivalent, in metropolitan Toronto, 1962.
    BOYD AR; MOSLEY W
    Can J Public Health; 1962 Aug; 53():326-9. PubMed ID: 13872138
    [No Abstract]   [Full Text] [Related]  

  • 60. [Preparation of inactivated poliomyelitis vaccine with attenuated Sabin strains].
    Abe S; Yamaki A; Doi Y
    Uirusu; 1986 Jun; 36(1):125-37. PubMed ID: 3776105
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.